{"lastClose": 3.2699999809265137, "len": 393, "date": "2023-01-06", "alpha_1": -0.21232801734139184, "beta_1": 1.6714899281865, "drawup_1": 1.2472826923210234, "natr_1": 21.345644303827164, "sup_1": -0.022426074564208018, "res_1": 0.8251783728245399, "bullPattern_1": [], "bearPattern_1": [], "rsi_1": 34.99999727521624, "adx_1": 41.50263266187105, "drawdown_1": -0.6638452457665858, "stratHoldSharpe_1": -0.40457329013981336, "stratHoldAlpha_1": 250.69604688040656, "stratHoldDrawdown_1": -0.6109050689544346, "alpha_3mo": -0.9768494108449747, "beta_3mo": 1.7020645000840482, "drawup_3mo": 0.28776976998181425, "natr_3mo": 21.345644303827164, "sup_3mo": -0.2344546589348079, "res_3mo": 0.04638126042595222, "bullPattern_3mo": ["HARAMI", "HOMINGPIGEON"], "bearPattern_3mo": [], "rsi_3mo": 49.74874395941373, "adx_3mo": 28.77096303104528, "drawdown_3mo": -0.599423638549192, "stratHoldSharpe_3mo": -3.5585159364614176, "stratHoldAlpha_3mo": 248.51994154149182, "stratHoldDrawdown_3mo": -0.5397923939304076, "Market Cap": 819034685, "Name": "Lyell Immunopharma Inc.", "Sector": "Health Care", "Industry": "Biotechnology: Pharmaceutical Preparations", "Country": "United States", "IPO Year": 2021.0, "alpha%_1": 0.41864764935141996, "beta%_1": 0.9100260324198716, "drawup%_1": 0.9910015695844335, "natr%_1": 0.9999999999917253, "drawdown%_1": 0.09423910260737245, "stratHoldSharpe%_1": 0.3527511708918716, "stratHoldAlpha%_1": 0.19573842327166197, "stratHoldDrawdown%_1": 0.08848720178079872, "alpha%_3mo": 0.060009854088182754, "beta%_3mo": 0.9154138031802601, "drawup%_3mo": 0.5829767061879898, "natr%_3mo": 0.9999999999829439, "drawdown%_3mo": 2.089222976423263e-05, "stratHoldSharpe%_3mo": 0.0022879883172498795, "stratHoldAlpha%_3mo": 2.236645347195301e-06, "stratHoldDrawdown%_3mo": 2.9135810978587996e-05}